Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Lactoferrin oral care to improve gum health during pregnancy

Official title: Effectiveness of an Oral Care Protocol Based on Lactoferrin Toothpaste and Mouthwash in Pregnant Women for the Prevention of Periodontal Disease: A Randomized Controlled Clinical Trial

Run by University of Pavia · NCT07069140 · Data updated 2026-11-12

This will test whether adding a lactoferrin mouthwash to lactoferrin toothpaste plus regular professional cleanings improves gum health in pregnant women 14–28 weeks into pregnancy.

More Pregnancy trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment40 (estimated)
SponsorUniversity of Pavia
Academic / other
Locations1 site (Pavia, Lombardy)
StatusRecruiting
StartedJuly 30, 2025
Main results expectedJune 1, 2026
Study endsJune 10, 2026
Registry record updatedFebruary 20, 2026
Trial IDNCT07069140 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–45 who are 14–28 weeks pregnant, have periodontitis (Stages I–III, Grades A–B), at least 20 natural teeth, and can attend follow-up visits are ideal candidates.

Probably not a fit

People with systemic diseases affecting periodontal status, recent antibiotic or periodontal treatment, current smokers, those with high-risk pregnancies or allergies to product components, or those using conflicting medications/supplements are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled trial will enroll 40 pregnant women in their second trimester and randomly assign them to two home-care regimens combined with professional dental cleanings every three months. The intervention group will use both a lactoferrin-based toothpaste and lactoferrin-based mouthwash, while the control group will use only the lactoferrin-based toothpaste. Participants will be followed for six months with periodic periodontal examinations. The primary outcome is reduction in dental plaque measured by the Plaque Index, with secondary outcomes including gingival inflammation, probing pocket depth, clinical attachment level, and other periodontal indices.

Why it matters

Potential benefit: If successful, this approach could reduce dental plaque and gum inflammation during pregnancy using accessible home oral-care products alongside routine cleanings.

How similar studies have gone: Laboratory work and small clinical studies suggest lactoferrin can reduce oral pathogens and plaque, but this specific lactoferrin mouthwash-plus-toothpaste regimen in pregnant women is relatively novel and not yet widely proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women aged between 18 and 45 years
* Gestational age between 14 and 28 weeks at the time of enrollment (second trimester)
* Diagnosis of periodontitis according to the 2017 World Workshop classification (Stages I-III, Grades A-B)
* Presence of at least 20 natural teeth
* Willingness to comply with study procedures and attend follow-up visits
* Signed informed consent

Exclusion Criteria:

* History of systemic diseases that could affect periodontal status (e.g., diabetes mellitus, immunosuppression)
* Antibiotic or anti-inflammatory therapy within 3 months prior to enrollment Current use of probiotics, antioxidant supplements, or medicated mouthwashes
* Periodontal treatment within 6 months before enrollment
* High-risk pregnancy or pregnancy complications (e.g., preeclampsia, gestational diabetes)
* Smoking or tobacco use
* Known allergy to any of the investigational product components
* Participation in another clinical trial within the previous 3 months

Where it's running

  • Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
    Pavia, Lombardy, Italy
    Recruiting

Study contacts

  • Principal investigator: Andrea Scribante, Associate Professor — University of Pavia
  • Study coordinator: Andrea Scribante, Associate Professor
  • Email: andrea.scribante@unipv.it
  • Phone: +39 0382516223

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.